Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Wei‐Fan Hsu"'
Autor:
Che-Jui Chang, Wei-Fan Hsu, Long-Bin Jeng, Hsueh-Chou Lai, Shih-Chao Hsu, Te-Hung Chen, Hung-Wei Wang, Cheng-Yuan Peng
Publikováno v:
Current Oncology, Vol 30, Iss 12, Pp 10134-10141 (2023)
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality in Taiwan. Some patients with HCC are diagnosed with macrovascular invasion (MVI), which is associated with a poorer prognosis. In Taiwan, sorafenib is the first-line thera
Externí odkaz:
https://doaj.org/article/0ccac6a45d2a42199bc2e3ac71d0f1c8
Autor:
Po-Ku Chen, Wei-Fan Hsu, Cheng-Yuan Peng, Tsai-Ling Liao, Shih-Hsin Chang, Hsin-Hua Chen, Chu-Huang Chen, Der-Yuan Chen
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundNon-alcoholic fatty liver disease (NAFLD) is prevalent among rheumatoid arthritis (RA) patients, but its pathogenesis has rarely been explored. Galectin-9 (Gal-9) interacts with T cell immunoglobulin and mucin-containing-molecule-3 (TIM-3)
Externí odkaz:
https://doaj.org/article/1261a7d2a7604f22b6149756fd279616
Publikováno v:
Gut Microbes, Vol 15, Iss 2 (2023)
ABSTRACTPast studies have confirmed the etiologies of bacterial extracellular vesicles (BEVs) in various diseases, including inflammatory bowel disease (IBD) and colorectal cancer (CRC). This study aimed to investigate the characteristics of stool-de
Externí odkaz:
https://doaj.org/article/6e046f233cee4182a402b8b8170c7af3
Autor:
Alberto Binetti, Wei-Fan Hsu, Koen Schouteden, Jin Won Seo, Jean-Pierre Locquet, Maria Recaman Payo
Publikováno v:
Results in Physics, Vol 49, Iss , Pp 106480- (2023)
Vanadium sesquioxide (V2O3) is a strongly correlated electron material exhibiting two distinct metal–insulator transitions that can be tuned via strain, doping, or pressure, making it an interesting material for new-generation sensors or smart devi
Externí odkaz:
https://doaj.org/article/981c6b7369044495acf6796285699852
Autor:
Sheng-Hung Chen, Hsueh-Chou Lai, Wen-Pang Su, Jung-Ta Kao, Po-Heng Chuang, Wei-Fan Hsu, Hung-Wei Wang, Tsung-Lin Hsieh, Hung-Yao Chen, Cheng-Yuan Peng
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2022 (2022)
Aims. Long-term risk stratification using combined liver stiffness (LS) and clinically relevant blood tests acquired at the baseline further beyond the sustained virologic response (SVR) visit for chronic hepatitis C (CHC) has not been thoroughly inv
Externí odkaz:
https://doaj.org/article/5214548ac190418186a4b35148f178ee
Autor:
Wei-Fan Hsu, Shih-Chao Hsu, Te-Hong Chen, Chien-Hung Lin, Ying-Chun Lin, Yu-Wei Chang, Hung-Wei Wang, Yu-Min Liao, Hsueh-Chou Lai, Cheng-Yuan Peng
Publikováno v:
Cancers, Vol 14, Iss 20, p 5083 (2022)
Albumin–bilirubin (ALBI) grade is an objective and reproducible model for evaluating overall survival (OS) in patients with hepatocellular carcinoma (HCC). However, the original ALBI grade was established for patients with Child–Pugh classes A–
Externí odkaz:
https://doaj.org/article/cae327308c6a4b47a2bc5dca94f63306
Autor:
Chun-Ting Kuo, Chen-Lin Chen, Chih-Chi Li, Guan-Syuan Huang, Wei-Yuan Ma, Wei-Fan Hsu, Ching-Hung Lin, Yen-Shen Lu, Andrew M. Wo
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Abstract When breast cancer patients start to exhibit resistance to hormonal therapy or chemotherapy, the mTOR inhibitor everolimus can be considered as an alternative therapeutic agent. Everolimus can deregulate the PI3K/AKT/mTOR pathway and affect
Externí odkaz:
https://doaj.org/article/c7eb9d6b994340dfae24eaf48c223d35
Autor:
Wei-Fan Hsu, Hsueh-Chou Lai, Wen-Pang Su, Chia-Hsin Lin, Po-Heng Chuang, Sheng-Hung Chen, Hung-Yao Chen, Hung-Wei Wang, Guan-Tarn Huang, Cheng-Yuan Peng
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Studies on temporal changes in noninvasive fibrosis indices and liver stiffness measurement (LSM) in patients with chronic hepatitis C (CHC) treated with direct-acting antiviral agents (DAAs) are limited. Methods We retrospectivel
Externí odkaz:
https://doaj.org/article/92d41d3b9efa4cdbb13e873213cefe0f
Autor:
Hung-Wei Wang, Po-Heng Chuang, Wen-Pang Su, Jung-Ta Kao, Wei-Fan Hsu, Chun-Che Lin, Guan-Tarn Huang, Jaw-Town Lin, Hsueh-Chou Lai, Cheng-Yuan Peng
Publikováno v:
Cancers, Vol 13, Iss 15, p 3758 (2021)
In the RESORCE study, regorafenib after sorafenib therapy improved survival in patients with advanced hepatocellular carcinoma (HCC). In total, 88 patients with unresectable HCC who received sorafenib–regorafenib sequential therapy were enrolled. T
Externí odkaz:
https://doaj.org/article/59d0b5b5331f4ba681f3a0128d582885
Autor:
Hung-Wei Wang, Cheng-Yuan Peng, Hsueh-Chou Lai, Wen-Pang Su, Chia-Hsin Lin, Po-Heng Chuang, Sheng-Hung Chen, Ching-Hsiang Chen, Wei-Fan Hsu, Guan-Tarn Huang
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Abstract We developed an optimal noninvasive index comprising routine laboratory parameters for predicting cirrhosis in chronic hepatitis B (CHB) and chronic hepatitis C (CHC) patients. This study included 992 CHB patients and 1,284 CHC patients who
Externí odkaz:
https://doaj.org/article/cc1029e1a2ce4eee8fc4dfff953da495